Skip to main content
search
All Posts By

Ben Kemp

Regulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

The Biocidal Products (Data Protection Periods) (Amendment) Regulations 2025

Please note the below update to the UK Biocidal products regulation: The Biocidal Products (Data Protection Periods) (Amendment) Regulations 2025 These Regulations amend Article 95 of Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (EUR 2012/528) (“the GB Biocidal Products…
Ben Kemp
December 10, 2025
Regulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

Biocides: Changes to Article 95 of GB Biocidal Products Regulation

Dear members, please be advised that if you are submitting data in support of a Biocides application that the data protection periods are being extended as per the below notification. Changes to Article 95 of GB Biocidal Products Regulation Regulations have been laid in Parliament to change the data protection end date in Article 95(5) to 31 December 2030. The…
Ben Kemp
December 10, 2025
Industry Newsletters Regulatory Affairs NewsletterIndustry Newsletters Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter Archive

Windows 10 end of support: Potential impact on medical devices

Dear members, please see below TGA post regarding Windows 10 end of support: Potential impact on medical devices. It doesn’t take into account LTSC Enterprise licences (End of support 12 Jan 2027) or Enterprise IoT licences which have an end of support scheduled in 2032. Some medical devices could be affected by the end of support for the Microsoft Windows…
Ben Kemp
December 10, 2025
Membership NewsMembership News Archive

What US–UK agreement on pharmaceuticals and tariff measures means for diagnostics

Last week, the UK and US Government's signed a pharmaceuticals and tariff deal which secured a 0% tariff on all pharmaceutical exports to the US for at least three years. This marks a further step in the UK-US Economic Prosperity deal, signed in May. Most importantly for UK IVD companies, the deal confirms 'preferential terms' for the UK’s MedTech exports…
Ben Kemp
December 9, 2025
Membership NewsMembership News Archive

BIVDA Migrates to New Membership System: GlueUp

BIVDA is pleased to announce the launch of our new membership system and CRM, Glue Up, which has gone live Today, Wednesday 10th December 2025. This upgraded platform will enhance how we communicate with you and provide easier access to exclusive member benefits — including events, webinars, and working party information — all in one place. Through the Glue Up online…
Ben Kemp
December 9, 2025
Close Menu